International Journal of Pharmaceutical Compounding.
Int J Pharm Compd. 2021 Mar-Apr;25(2):131-139.
Intravenous admixture compounding is common practice in most hospitals throughout the world, regardless of the country. Compounding intravenous medications involves risk, as there is a high potential for error due to their complexity in compounding, and working in an aseptic environment itself poses issues for the compounder. Part 9-A of this series of articles on the topic of intravenous admixture preparation considerations discusses 1) the background, 2) types of errors, 3) where errors can occur, 4) automated parenteral nutrition compounding systems, 5) accuracy and strength issues, and 6) medication error prevention. Part 9-B of this series of articles will include 1) a discussion on standardization (of both formulas and procedures), 2) competency, 3) compliance, 4) a detailed table on the sources of errors, and 5) the considerations for the prevention of errors.
静脉药物混合调配在世界上大多数国家的医院中都很常见。静脉药物配制涉及风险，因为由于其配制的复杂性，存在很高的出错的可能性，而且在无菌环境中工作本身也会给配制者带来问题。本系列关于静脉药物混合调配准备考虑因素的文章的第 9-A 部分讨论了 1）背景，2）错误类型，3）错误可能发生的地方，4）自动化肠外营养混合配制系统，5）准确性和强度问题，以及 6）药物错误预防。本系列文章的第 9-B 部分将包括 1）对公式和程序的标准化的讨论，2）能力，3）合规性，4）一个关于错误来源的详细表格，以及 5）预防错误的考虑因素。
